Loading...
The progress of targeted therapy in advanced gastric cancer
Although palliative chemotherapy has been shown to prolong survival and improve quality of life, the survival of advanced gastric cancer (AGC) patients remains poor. With the advent of targeted therapy, many molecular targeted agents have been evaluated in clinical studies. Trastuzumab, an anti-HER2...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3878836/ https://ncbi.nlm.nih.gov/pubmed/24330856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2050-7771-1-32 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|